{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:40:53Z","timestamp":1776040853151,"version":"3.50.1"},"reference-count":18,"publisher":"S. Karger AG","issue":"6","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Res Treat"],"published-print":{"date-parts":[[2004]]},"DOI":"10.1159\/000081335","type":"journal-article","created":{"date-parts":[[2005,1,20]],"date-time":"2005-01-20T08:44:42Z","timestamp":1106210682000},"page":"540-544","source":"Crossref","is-referenced-by-count":13,"title":["Clinical Phase II Study of Pegylated Liposomal Doxorubicin as Second-Line Treatment in Disseminated Melanoma"],"prefix":"10.1159","volume":"27","author":[{"given":"MS.","family":"Ugurel","sequence":"first","affiliation":[]},{"given":"D.","family":"Schadendorf","sequence":"additional","affiliation":[]},{"given":"W.","family":"Fink","sequence":"additional","affiliation":[]},{"given":"C.","family":"Zimpfer-Rechner","sequence":"additional","affiliation":[]},{"given":"A.","family":"Thoelke","sequence":"additional","affiliation":[]},{"given":"R.","family":"Figl","sequence":"additional","affiliation":[]},{"given":"M.","family":"Kaatz","sequence":"additional","affiliation":[]}],"member":"127","published-online":{"date-parts":[[2004,12,8]]},"reference":[{"key":"p_1_272","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.07.070"},{"key":"p_3_273","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/1097-0142(19931115)72:10<3091::AID-CNCR2820721034>3.0.CO;2-V","volume":"72","author":"Sirott MN","year":"1993","journal-title":"Cancer"},{"key":"p_4_274","doi-asserted-by":"publisher","DOI":"10.1159\/000055210"},{"key":"p_5_275","first-page":"81","volume":"10","author":"Lee ML","year":"2000","journal-title":"Melanoma Res"},{"key":"p_6_276","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199700544-00003","volume":"54","author":"Hortobagyi GN","year":"1997","journal-title":"Drugs"},{"key":"p_7_277","first-page":"683","volume":"16","author":"Stewart S","year":"1998","journal-title":"International Pegylated Liposomal Doxorubicin Study Group. J Clin Oncol"},{"key":"p_8_278","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1200\/JCO.2001.19.14.3312","volume":"19","author":"Gordon AN","year":"2001","journal-title":"J Clin Oncol"},{"key":"p_9_279","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1200\/JCO.1995.13.7.1777","volume":"13","author":"Uziely B","year":"1995","journal-title":"J Clin Oncol"},{"key":"p_10_280","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2165\/00003495-199700544-00007","volume":"54","author":"Alberts DS","year":"1997","journal-title":"Drugs"},{"key":"p_11_281","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/1097-0142(19940101)73:1<103::AID-CNCR2820730119>3.0.CO;2-K","volume":"73","author":"Schadendorf D","year":"1994","journal-title":"Cancer"},{"key":"p_12_282","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jnci\/85.17.1432","volume":"85","author":"Vukelja SJ","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"p_13_283","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-111-8-688","volume":"111","author":"Vukelja SJ","year":"1989","journal-title":"Ann Intern Med"},{"key":"p_14_284","first-page":"1567","volume":"4","author":"Vail DM","year":"1998","journal-title":"Clin Cancer Res"},{"key":"p_15_285","doi-asserted-by":"publisher","DOI":"10.1007\/s004320000178"},{"key":"p_16_286","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.12.1475"},{"key":"p_17_287","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008346925273"},{"key":"p_18_288","first-page":"1097","volume":"6","author":"Ellerhorst JA","year":"1999","journal-title":"Oncol Rep"},{"key":"p_19_289","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200304000-00015"}],"container-title":["Oncology Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/81335","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/81335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T03:43:38Z","timestamp":1745466218000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000081335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2004,12,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000081335","archive":["Portico"],"relation":{},"ISSN":["2296-5270","2296-5262"],"issn-type":[{"value":"2296-5270","type":"print"},{"value":"2296-5262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004]]}}}